Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion type Assertion NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_head.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion description "[After imatinib (IM) treatment, patients with m-bcr showed higher BCR-ABL relative concentrations in both CML-CP and ALL groups.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_provenance.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion evidence source_evidence_literature NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_provenance.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion SIO_000772 25520136 NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_provenance.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion wasDerivedFrom befree-2016 NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_provenance.
- NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_assertion wasGeneratedBy ECO_0000203 NP1249111.RA50wxE5Okpljata6YHqfuZSRV52VtAN4hcjWUyNeSf0c130_provenance.